Skip to content

A comparison of intravenous nefopam and fentanyl for patient controlled analgesia in patients with two jaw surgery

A comparison of intravenous nefopam and fentanyl for patient controlled analgesia in patients with oral and maxillofacial surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0001592
Enrollment
174
Registered
2015-08-10
Start date
2015-08-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The study is conducted in patients who want the patient controlled analgesia after the two jaw surgery, come up to a standard and agree to the informed consent. Before the operation researcher

Sponsors

Seoul National University Dental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who agree with the study receive the intravenous patient controlled analgesia after two jaw surgery. They are belonged to American Society of Anesthesiologists classification I,II or III, aged 20 to 40.

Exclusion criteria

Exclusion criteria: Patients aged under 20 years old, patients under the emergency operations, patients who had already the sedatives or analgesic drug which could have impact on the sleep or pain. Patients with the chronic obstructive pulmonary disease or asthma. Patients who had the upper respiratory infection within 2 weeks. Patient who have chronic pain disease, smoker, heart disease, hepatic disease or kidney disease. In addition patients who are identified to be inappropriate for the study by physician.

Design outcomes

Primary

MeasureTime frame
the postoperative nausea and vomiting(PONV)

Secondary

MeasureTime frame
the postoperative pain;The postoperative shivering;The quality of sleep;The satisfaction from the PCA;The total volume of infusion, times of bolus attempt, times of bolus infusion;The dose of additive analgesics and additive antiemetics

Countries

Korea, Republic of

Contacts

Public ContactSookyung Park

Seoul National University Dental Hospital

wamir50@gmail.com+82-2-2072-3847

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026